VERTEX PHARMACEUTIC
VERTEX PHARMACEUTIC operates in Diversified Metals & Mining.
Market Cap & Net Worth: VERTEX PHARMACEUTIC (VX1)
VERTEX PHARMACEUTIC (MU:VX1) has a market capitalization of $4.00 Million (€3.90 Million) as of March 19, 2026. Listed on the MU stock exchange, this Germany-based company holds position #31954 globally and #3546 in its home market, demonstrating a 4.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VERTEX PHARMACEUTIC's stock price €427.15 by its total outstanding shares 9126 (9.13K).
VERTEX PHARMACEUTIC Market Cap History: 2015 to 2026
VERTEX PHARMACEUTIC's market capitalization history from 2015 to 2026. Data shows growth from $1.09 Million to $4.00 Million (14.99% CAGR).
VERTEX PHARMACEUTIC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VERTEX PHARMACEUTIC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
VERTEX PHARMACEUTIC's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
VERTEX PHARMACEUTIC's market cap is 0.00 times its annual earnings
0.00x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $658.73K | $1.70 Billion | -$112.05 Million | 0.00x | N/A |
| 2017 | $1.18 Million | $2.49 Billion | $263.48 Million | 0.00x | 0.00x |
| 2018 | $1.33 Million | $3.05 Billion | $2.10 Billion | 0.00x | 0.00x |
| 2019 | $1.84 Million | $4.16 Billion | $1.18 Billion | 0.00x | 0.00x |
| 2020 | $1.78 Million | $6.21 Billion | $2.71 Billion | 0.00x | 0.00x |
| 2021 | $1.84 Million | $7.57 Billion | $2.34 Billion | 0.00x | 0.00x |
| 2022 | $2.51 Million | $8.93 Billion | $3.32 Billion | 0.00x | 0.00x |
| 2023 | $3.47 Million | $9.87 Billion | $3.62 Billion | 0.00x | 0.00x |
Competitor Companies of VX1 by Market Capitalization
Companies near VERTEX PHARMACEUTIC in the global market cap rankings as of March 19, 2026.
Key companies related to VERTEX PHARMACEUTIC by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
VERTEX PHARMACEUTIC Historical Marketcap From 2015 to 2026
Between 2015 and today, VERTEX PHARMACEUTIC's market cap moved from $1.09 Million to $ 4.00 Million, with a yearly change of 14.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €4.00 Million | +9.04% |
| 2025 | €3.67 Million | +1.36% |
| 2024 | €3.62 Million | +4.45% |
| 2023 | €3.47 Million | +37.87% |
| 2022 | €2.51 Million | +36.34% |
| 2021 | €1.84 Million | +3.59% |
| 2020 | €1.78 Million | -3.42% |
| 2019 | €1.84 Million | +38.68% |
| 2018 | €1.33 Million | +12.62% |
| 2017 | €1.18 Million | +79.15% |
| 2016 | €658.73K | -39.45% |
| 2015 | €1.09 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of VERTEX PHARMACEUTIC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.00 Million USD |
| MoneyControl | $4.00 Million USD |
| MarketWatch | $4.00 Million USD |
| marketcap.company | $4.00 Million USD |
| Reuters | $4.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.